Xponance, Inc. 10x Genomics, Inc. Transaction History

Xponance, Inc.

$10.1 Billion
Q1 2025

A detailed history of Xponance, Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 12,010 shares of TXG stock, worth $167,059. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,010

Previous 10,232 17.38%

Holding current value

$167,059

Previous $146,000 28.77%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	BUY	$8.73 - $16.31 $15,521 - $28,999	1,778 Added 17.38%	12,010 $104,000
Q4 2024 Feb 10, 2025	SELL	$13.18 - $21.31 $2,385 - $3,857	-181 Reduced 1.74%	10,232 $146,000
Q3 2024 Nov 12, 2024	BUY	$15.71 - $23.49 $3,142 - $4,698	200 Added 1.96%	10,413 $235,000
Q2 2024 Aug 14, 2024	SELL	$19.45 - $37.37 $27,580 - $52,990	-1,418 Reduced 12.19%	10,213 $198,000
Q1 2024 May 13, 2024	SELL	$36.08 - $54.3 $17,462 - $26,281	-484 Reduced 4.0%	11,631 $436,000
Q4 2023 Jan 31, 2024	SELL	$34.32 - $57.55 $32,432 - $54,384	-945 Reduced 7.24%	12,115 $677,000
Q3 2023 Oct 23, 2023	BUY	$40.86 - $62.98 $16,344 - $25,192	400 Added 3.16%	13,060 $538,000
Q2 2023 Jul 13, 2023	BUY	$50.96 - $58.72 $50,399 - $58,074	989 Added 8.47%	12,660 $706,000
Q1 2023 Apr 17, 2023	BUY	$35.33 - $55.79 $16,039 - $25,328	454 Added 4.05%	11,671 $651,000
Q4 2022 Jan 23, 2023	BUY	$24.4 - $41.3 $27,767 - $46,999	1,138 Added 11.29%	11,217 $0
Q3 2022 Oct 24, 2022	BUY	$28.48 - $52.59 $15,891 - $29,345	558 Added 5.86%	10,079 $287,000
Q2 2022 Aug 02, 2022	SELL	$36.95 - $82.41 $739 - $1,648	-20 Reduced 0.21%	9,521 $431,000
Q1 2022 Apr 20, 2022	SELL	$55.7 - $145.79 $3,397 - $8,893	-61 Reduced 0.64%	9,541 $726,000
Q4 2021 Jan 31, 2022	BUY	$135.05 - $182.59 $30,116 - $40,717	223 Added 2.38%	9,602 $1.43 Million
Q3 2021 Nov 05, 2021	SELL	$145.58 - $192.14 $57,649 - $76,087	-396 Reduced 4.05%	9,379 $1.37 Million
Q2 2021 Aug 12, 2021	BUY	$134.22 - $202.37 $506,143 - $763,137	3,771 Added 62.81%	9,775 $1.91 Million
Q1 2021 May 10, 2021	BUY	$140.25 - $196.86 $14,025 - $19,686	100 Added 1.69%	6,004 $1.09 Million
Q4 2020 Feb 11, 2021	SELL	$126.47 - $163.7 $6,070 - $7,857	-48 Reduced 0.81%	5,904 $836,000
Q3 2020 Oct 26, 2020	BUY	$87.44 - $125.0 $28,418 - $40,625	325 Added 5.78%	5,952 $742,000
Q2 2020 Aug 14, 2020	BUY	$58.39 - $89.31 $328,560 - $502,547	5,627 New	5,627 $503,000

Others Institutions Holding TXG

# of Institutions

305

Shares Held

111M

Call Options Held

228K

Put Options Held

157K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.32B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account